SCHEMBL23309612

SCHEMBL23309612

CC(C)(C)Oc1cccc(NC(=O)c2cc(F)nc(F)c2F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 1/20 0.47
▸ RAB9A P51151 5/20 0.47
▸ NPC1 O15118 4/20 0.47
▸ P2RX1 P51575 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ POLB P06746 2/20 0.44
▸ TRPV1 Q8NER1 1/20 0.43
▸ KCNK3 O14649 1/20 0.42
▸ KCNK9 Q9NPC2 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ SCN8A Q9UQD0 1/20 0.41
▸ SCN10A Q9Y5Y9 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309615 0.89 P2RX1 (0.58) GRM4RAB9ANPC1P2RX1KCNK3
SCHEMBL23309513 0.87 RAB9A (0.63) GRM4RAB9ANPC1KDM4EPOLB
SCHEMBL23309528 0.87 PRSS12 (0.44) RAB9ANPC1TRPV1SMN1; SMN2SCN8A
SCHEMBL23309593 0.86 GRM4 (0.52) GRM4RAB9ANPC1KDM4EPOLB
SCHEMBL23309511 0.84 KMT2A (0.52) RAB9ANPC1POLBKCNK3KCNK9
SCHEMBL23309585 0.83 KDM4E (0.52) GRM4RAB9ANPC1KDM4EPOLB
SCHEMBL23309536 0.80 MEN1 (0.55) RAB9ANPC1KDM4EKCNK3KCNK9
SCHEMBL23309490 0.78 GAA (0.51) RAB9ANPC1KDM4EPOLBTP53
SCHEMBL23309548 0.78 FADS1 (0.55) GRM4RAB9ANPC1P2RX1KDM4E
SCHEMBL23309730 0.77 KMT2A (0.47) RAB9ANPC1P2RX1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL GRM4 2885/4885RAB9A 286/4885NPC1 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback